Viemed Healthcare (FRA:VIJ) Other Stockholders Equity: €-0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:VIJ Viemed Healthcare Inc FRA:VIJ
93 GF Score
Price €10.30
GF Value €9.43
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Viemed Healthcare Other Stockholders Equity?

Viemed Healthcare FRA:VIJ +0.98% 93 Other Stockholders Equity is €-0.0 Mil as of Mar. 2026. GuruFocus rates FRA:VIJ with a GF Score™ of 93/100 and a GF Value™ of €9.43 (Fairly Valued). The stock has 7 warning signs investors should review.

Viemed Healthcare's Other Stockholders Equity for the quarter that ended in Mar. 2026 was €-0.0 Mil.

Viemed Healthcare's quarterly Other Stockholders Equity declined from Sep. 2025 (€0.0 Mil) to Dec. 2025 (€-0.0 Mil) but then stayed the same from Dec. 2025 (€-0.0 Mil) to Mar. 2026 (€-0.0 Mil).

Viemed Healthcare's annual Other Stockholders Equity declined from Dec. 2023 (€-0.0 Mil) to Dec. 2024 (€-0.0 Mil) but then stayed the same from Dec. 2024 (€-0.0 Mil) to Dec. 2025 (€-0.0 Mil).

Viemed Healthcare Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Viemed Healthcare's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viemed Healthcare Other Stockholders Equity Chart

Viemed Healthcare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.00 -0.00 -0.00 -0.00

Viemed Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.00 0.00 -0.00 -0.00
FRA:VIJ
93GF Score
Viemed Healthcare Inc FRA:VIJ
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viemed Healthcare Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €-0.0 Mil mean?
Viemed Healthcare (FRA:VIJ) has a Other Stockholders Equity of €-0.0 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Viemed Healthcare and its competitors.
Is Viemed Healthcare's Other Stockholders Equity too high?
Viemed Healthcare's current Other Stockholders Equity is €-0.0 Mil. Overall, Viemed Healthcare has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Viemed Healthcare's Other Stockholders Equity compare to DCTH and VREX?
Viemed Healthcare's Other Stockholders Equity of €-0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Viemed Healthcare and its competitors. Viemed Healthcare's current Other Stockholders Equity is €-0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viemed Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Viemed Healthcare (FRA:VIJ) is currently considered Fairly Valued. The stock's GF Value™ is €9.43, compared to a current price of €10.30 — trading 9.2% above its estimated fair value. The current Other Stockholders Equity is €-0.0 Mil. Viemed Healthcare's overall GF Score™ is 93/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Viemed Healthcare (FRA:VIJ), the current Other Stockholders Equity is €-0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Viemed Healthcare (FRA:VIJ) Overvalued in 2026?

Based on GuruFocus' analysis, Viemed Healthcare stock appears to be overvalued. The current stock price of €10.30 is trading 9.2% above its estimated GF Value™ of €9.43. GuruFocus considers Viemed Healthcare to be Fairly Valued.

Key valuation signals for FRA:VIJ:

  • Other Stockholders Equity: €-0.0 Mil
  • GF Value™: €9.43 vs. price of €10.30 (9.2% above fair value)
  • GF Score™: 93/100 with 7 warning signs

No single metric tells the full story. See the FRA:VIJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Viemed Healthcare Business Description

Other Exchanges VMD:USA
Address 625 E. Kaliste Saloom Road, Lafayette, LA, USA, 70508
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.
93GF Score

Get the complete analysis for FRA:VIJ

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.30
Price
€9.43
GF Value